Assessment of Sarcopenia

  • Daniel Bunout
  • Gladys Barrera RN
  • Pia de la Maza
  • Laura Leiva RT
  • Sandra Hirsch


Sarcopenia is defined as the loss of muscle mass that occurs during normal aging and is associated with functional impairment. This is a dynamic concept that should consider the reduction of muscle mass over time but, for practical purposes, we must rely on cross-sectional measures to determine the presence of a significant loss of muscle mass. Double energy X ray absorptiometry is a reasonably accurate and inexpensive method to determine body composition. Knowing the body composition of a representative sample of older subjects in a specific community, regression equations to predict muscle mass can be derived to determine which individuals are sarcopenic using the residuals method. Functional measures should also be incorporated in the assessment of sarcopenia. The most popular assessments include walking capacity, the ability to rise from a chair and the measurement of muscle strength using dynamometers. A lower muscle mass and function in older subjects are risk factors for mortality and disability. Physical training is the only intervention capable of reverting the adverse consequences of sarcopenia.


Obesity Hydration Osteoporosis Creatinine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Arroyo P, Lera L, Sánchez H, Bunout D, Santos JL, Albala C. Rev Med Chil. 2007;135:846–54.PubMedGoogle Scholar
  2. Bales CW, Ritchie CS. Annu Rev Nutr. 2002;22:309–23.PubMedGoogle Scholar
  3. Bunout D, Barrera G, De la Maza MP, Avendaño M, Gattás V, Petermann M, Hirsch S. J Nutr Health Aging 2004;8:37–48.PubMedGoogle Scholar
  4. Bunout D, Barrera G, Avendaño M, de la Maza P, Gattas V, Leiva L, Hirsch S. Results of a community-based ­weight-bearing resistance training programme for healthy Chilean elderly subjects. Age Ageing. 2005;34:80–3.PubMedGoogle Scholar
  5. Bunout D, Barrera G, Leiva L, Gattas V, de la Maza MP, Avendaño M, Hirsch S. Exp Gerontol. 2006;41:746–52.PubMedGoogle Scholar
  6. Bunout D, de la Maza MP, Barrera G, Leiva L, Gattas V, Hirsch S. Aging Clin Exp Res. 2007;19:295–9.PubMedGoogle Scholar
  7. Cawthon PM, Fox KM, Gandra SR, Delmonico MJ, Chiou CF, Anthony MS, Sewall A, Goodpaster B, Satterfield S, Cummings SR, Harris TB; Health, Aging and Body Composition Study. J Am Geriatr Soc. 2009;57:1411–9.PubMedGoogle Scholar
  8. Cawthon PM, Marshall LM, Michael Y, Dam TT, Ensrud KE, Barrett-Connor E, Orwoll ES. J Am Geriatr Soc. 2007;55:1216–23.PubMedGoogle Scholar
  9. Chen Z, Wang Z, Lohman T, Heymsfield SB, Outwater E, Nicholas JS, Bassford T, LaCroix A, Sherrill D, Punyanitya M, Wu G, Going S. J Nutr. 2007;137:2775–8.PubMedGoogle Scholar
  10. Cree MG, Newcomer BR, Katsanos CS, Sheffield-Moore M, Chinkes D, Aarsland A, Urban R, Wolfe RR. J Clin Endocrinol Metab. 2004;89:3864–71.PubMedGoogle Scholar
  11. Dillon EL, Sheffield-Moore M, Paddon-Jones D, Gilkison C, Sanford AP, Casperson SL, Jiang J, Chinkes DL, Urban RJ. J Clin Endocrinol Metab. 2009;94:1524–6.PubMedGoogle Scholar
  12. Georgiou E, Virvidakis K, Douskas G, Lambrinoudaki I, Voudiklari S, Katsoudas S, Mountokalakis T, Proukakis C. Metabolism. 1997;46: 1059–62.PubMedGoogle Scholar
  13. Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R. J Appl Physiol. 2000;89:104–10.PubMedGoogle Scholar
  14. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB. J Gerontol A Biol Sci Med Sci. 1995;55:M221–31.PubMedGoogle Scholar
  15. Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc. 2006;54:56–62.PubMedGoogle Scholar
  16. Lee JS, Visser M, Tylavsky FA, Kritchevsky SB, Schwartz AV, Sahyoun N, Harris TB, Newman AB; for the Health ABC study. J Gerontol A Biol Sci Med Sci. 2009;Apr 14. [Epub ahead of print].Google Scholar
  17. McGavin CR, Gupta SP, McHardy GJ. Br Med. 1967;1:822–3.PubMedGoogle Scholar
  18. Metter EJ, Talbot LA, Schrager M, Conwit R. J Gerontol A Biol Sci Med Sci. 2002;57A:B359–65.PubMedGoogle Scholar
  19. Miller DK, Malmstrom TK, Andresen EM, Miller JP, Herning MM, Schootman M, Wolinsky FD. J Gerontol A Biol Sci Med Sci. 2009;64:388–94.PubMedGoogle Scholar
  20. Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO. Ann Intern Med. 2008;149:601–11.PubMedGoogle Scholar
  21. Price GM, Uauy R, Breeze E, Bulpitt CJ, Fletcher AE. Am J Clin Nutr. 2006;84:449–60.PubMedGoogle Scholar
  22. Rockwood K, Awalt E, Carver D, MacKnight C. J Gerontol A Biol Sci Med Sci. 2000;55:M70–3.PubMedGoogle Scholar
  23. Rolland Y, Lauwers-Cances V, Cristini C, Abellan van Kan G, Janssen I, Morley JE, Vellas B. Am J Clin Nutr. 2009;89:1895–900.PubMedGoogle Scholar
  24. Sayer AA, Syddall HE, Martin HJ, Dennison EM, Roberts HC, Cooper C. Age Ageing. 2006;35:409–15.PubMedGoogle Scholar
  25. Shafer KJ, Siders WA, Johnson LK, Lukaski HC. Nutrition. 2009;25:25–32.PubMedGoogle Scholar
  26. Tainaka K, Takizawa T, Katamoto S, Aoki J. Geriatr Gerontol Int. 2009;9:21–8.PubMedGoogle Scholar
  27. The World Health Organization (WHO) study group on Osteoporosis. Assessment of fracture risk and its application to screening for osteoporosis. Geneva: World Health Organization; 1994.Google Scholar
  28. Torriani M, Thomas BJ, Halpern EF, Jensen ME, Rosenthal DI, Palmer WE. Radiology. 2005;236:609–14.PubMedGoogle Scholar
  29. Williams J E, Wells J C, Wilson C M, Haroun D, Lucas A, Fewtrell MS. Am J Clin Nutr. 2006;83:1047–54.PubMedGoogle Scholar
  30. Zainal TA, Oberley TD, Allison DB, Szweda LI, Weindruch R. FASEB J. 2000;14:1825–36.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Daniel Bunout
    • 1
  • Gladys Barrera RN
  • Pia de la Maza
  • Laura Leiva RT
  • Sandra Hirsch
  1. 1.Institute of Nutrition and Food Technology (INTA)University of ChileSantiagoChile

Personalised recommendations